Results 311 to 320 of about 452,381 (401)

Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed‐ratio basal insulin glucagon‐like peptide‐1 receptor agonist combinations?

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Basal insulin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are available in two fixed‐ratio combinations (FRCs) for the treatment of type 2 diabetes (T2D), insulin degludec with liraglutide and insulin glargine with lixisenatide.
Kevin Cowart, Nicholas W. Carris
wiley   +1 more source

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This indirect treatment comparison (ITC) compared the efficacy and safety of tirzepatide with semaglutide for managing obesity or overweight in participants with type 2 diabetes (T2D), informed by the pivotal trials SURMOUNT‐2 and STEP 2.
Andreea Ciudin, Erin Johansson, Sarah Zimner‐Rapuch, Georgios K. Dimitriadis, Marine Bertrand, Tristan Curteis, Laura J. Clark, Ludi Fan, Helene Sapin, Jean‐Francois Bergmann   +9 more
wiley   +1 more source

A case of acute renal injury and renal artery stenosis caused by cholesterol crystal embolization after coronary stenting: Improved by a combination therapy

Chronic Diseases and Translational Medicine, 2021
Xiaohui Yan, Yanting Zhu, Xiaoming Wang, Zhenjiang Li   +3 more
doaj  

The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types. [PDF]

J Clin Med
Szymczak M, Heidecke H, Żabińska M, Janek Ł, Wronowicz J, Kujawa K, Schulze-Forster K, Marek-Bukowiec K, Gołębiowski T, Banasik M.   +9 more
europepmc   +1 more source

Glomerular function in advanced human diabetic nephropathy

, 1982
Jan A. Winetz, Helen Golbetz, Robin J. Spencer, Jeri A. Lee, Bryan D. Myers   +4 more
openalex   +1 more source

PIONEER REAL Spain: A multicentre, prospective, real‐world study of oral semaglutide use in adults with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This study evaluated clinical outcomes of oral semaglutide treatment in adults with type 2 diabetes (T2D) in a real‐world setting in Spain as part of the 13‐country PIONEER REAL programme. Materials and Methods This multicentre, prospective, non‐interventional, single‐arm study (NCT05443334) followed participants for 34–44 weeks ...
Elías Delgado Álvarez, Cristóbal Morales Portillo, Cristina Abreu Padín, Alberto Aliaga Verdugo, Ana Piera Carbonell, Aída Cadenas González, Jaime Amor Valero, Verónica González López, Christina Louise Rasmussen, Stine Hedegaard Scheuer, Diego Bellido Guerrero   +10 more
wiley   +1 more source

Diabetic Nephropathy

, 2012
Vujičić, Božidar, Turk, Tamara, Crnčević-Orlić, Željka, Đorđević, Gordana, Rački, Sanjin   +4 more
openaire   +5 more sources

Tissue-specific mitochondrial DNA, <i>MT-TF,</i> pathogenic variants in mitochondrial myopathies. [PDF]

Mol Genet Metab Rep
Rose S, Trimouille A, Lacombe D, Malfatti E, Assouline Z, Steffann J, Desguerre I, Munnich A, Rötig A, Barcia G.   +9 more
europepmc   +1 more source

MEMBRANOUS NEPHROPATHY IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS

, 1989
G. Montagnino, Carla Colturi, Giovanni Banfi, A. Aroldi, Antonio Tarantino, Claudio Ponticelli   +5 more
openalex   +1 more source